FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Lowers Opinion On Shares Of American Airlines Group Inc. To Sell From Hold

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our opinion on AAL to Sell from Hold, reduce our price target by $1 to $12, and cut our 2026 EPS to -$0.07 from $0.48 and 2027's to $1.72 from $1.93, primarily reflecting fuel costs. Our target reflects 7x 2027 EPS (from 6.5x), with the modest multiple expansion reflecting strong underlying industry travel trends despite higher airfare, partially offsetting our estimate reductions. In our view, AAL is most exposed to fuel costs, given a higher unit cost profile and lagging unit revenue performance versus peers. While Q1 unit revenue rose 6.5% Y/Y, the spread between AAL's unit revenue and unit costs (+5.2% Y/Y) is tighter than peers and could result in operating losses more quickly. This profile justifies our discounted multiple versus peers in the high-single-digit range. AAL is also leaning into summer capacity, potentially driving higher fuel consumption at elevated prices. We see limited margin for error if fuel headwinds persist. A key upside risk is oil prices easing faster than expected.

Related Articles

Research

Research Alert: Fedex Completes Freight Spin-off; Legacy Business Less Attractive Post-split

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FedEx completed the spin-off of FedEx Freight as FDXF on June 1, 2026, with shares beginning NYSE trading and FDX up modestly after adjusting for the 1:2 distribution. FDX retains 19.9% of FDXF shares for release over 24 months through debt repayment, special dividend, or share exchange options. We view the spin-off as a net positive for existing shareholders, allowing them to benefit from less-than-truckload firms' typical premium valuations over diversified shipping companies while essentially maintaining combined exposure. FDX will report FY 26 (May) results on June 23 reflecting the combined company through May 31. However, we see the legacy FDX business as less attractive due to the shift toward B2C from B2B customers, which comprised the majority of FedEx Freight volume. We think this business mix change dilutes a key competitive advantage over UPS, particularly given our concerns about unsustainable consumer spending habits and the Iran conflict accelerating pullback likelihood.

$FDX
Research

Macquarie Downgrades Caesars Entertainment to Neutral From Outperform

Caesars Entertainment (CZR) has an average rating of overweight and mean price target of $31.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $29.12, Change: $+0.06, Percent Change: +0.22%

$CZR
Research

Research Alert: CFRA Moves To Hold From Sell On Shares Of Taylor Morrison Homes Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Berkshire Hathaway announced the acquisition of TMHC for $72.50/share in cash, a 24% premium to the May 29 closing price. Prior to the announcement, TMHC was trading near our $57 price target. We view the acquisition as a validation of the long-term fundamentals in the homebuilding industry. However, we think the move also supports our believe that near-term performance will remain choppy, with homebuilders possessing large balance sheets and diversified consumer bases better positioned to navigate headwinds. We see the acquisition as a diversification effort, especially as the transaction signals a departure from Berkshire's strategy of allowing acquisitions to operate independently. CEO Greg Abel indicated plans to unify operations with Berkshire's housing assets, including Clayton Homes. We note Clayton is more exposed to entry level, while TMHC's product portfolio is more diverse. Our 12-month price of $72 is 11.5x our 2027 EPS of $6.26, a premium to the 7.2x 10-year mean. Our EPS estimates remain unchanged.

$TMHC